Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
Merck to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
06:45am, Tuesday, 05'th Sep 2023
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference.
Judge withdraws from Medicare drug price case after stock ownership is revealed
05:23pm, Friday, 01'st Sep 2023
Judge Thomas Rose of the U.S. District Court for the Southern District of Ohio withdrew from a case that could block Medicare's drug price negotiation program.
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?
07:01am, Friday, 01'st Sep 2023
Major pharmaceutical companies including Johnson & Johnson NYSE: JNJ, Novartis AG NYSE: NVS, Bristol-Myers Squibb (NYSE: BMY), Merck & Co., Inc. NYSE: MRK, Eli Lilly & Co. NYSE: LLY and Amgen In
Why Is Merck (MRK) Up 4.3% Since Last Earnings Report?
12:48pm, Thursday, 31'st Aug 2023
Merck (MRK) reported earnings 30 days ago. What's next for the stock?
Should You Pick Merck Stock Over Coca-Cola?
08:00am, Thursday, 31'st Aug 2023
We compare their current multiples with the historical ones in the sections below to better gauge their valuations.
Medicare drug price negotiations may have a muted impact on drugmakers in the near term
01:48pm, Wednesday, 30'th Aug 2023
Many of the drugs are already facing strong competition from other branded medications or patent expirations that will open the market to generic alternatives.
Merck's (MRK) Keytruda Receives EU Nod in Gastric Cancer
01:31pm, Wednesday, 30'th Aug 2023
Following the approval, Merck's (MRK) Keytruda is the first immunotherapy approved in the EU for first-line treatment for HER2-positive advanced gastric cancer in adults whose tumors express PD-L1.
Cantor's Louise Chen breaks down new Medicare drug pricing negotiations
03:02pm, Tuesday, 29'th Aug 2023
Louise Chen, Cantor Fitzgerald, joins 'Power Lunch' to discuss Medicare drug priced ahead of Biden's news conference on the negotiations.
Steady Eddies: 7 Unshakeable Stocks for Any Type of Market
12:29pm, Tuesday, 29'th Aug 2023
If there's any one theme that supports the concept of safe stocks to buy, it's ambiguity. At first glance, Federal Reserve Chair Jerome Powell recently clarified that while inflation is finally moving
10 Drugs Selected for Medicare Price Reduction
12:01pm, Tuesday, 29'th Aug 2023
We're getting Case-Shiller home price numbers ahead of the opening bell this morning, but there's not enough time to dig into it. Give us till this afternoon to speak about these.
Better Pharma Growth Stock: Eli Lilly vs. Merck
10:15am, Tuesday, 29'th Aug 2023
Eli Lilly's Mounjaro is shaping up to be a long-term driver of earnings growth. The same is true for Merck's Keytruda, a medication for treating certain cancers.
Merck, Amgen, AbbVie products among first 10 drugs selected for Medicare price negotiations
07:50am, Tuesday, 29'th Aug 2023
Medicare on Tuesday announced the first 10 drugs selected for price negotiations, launching a historic and highly contentious process with big implications for pharmaceutical companies, taxpayers and
Markets Up Second-Straight Day; Lots of Data On Deck
07:33pm, Monday, 28'th Aug 2023
All major indices are up over the past week of trading, though are still underwater for the past month.
Merck (MRK), Eisai to End Keytruda-Lenvima Combo Cancer Study
12:02pm, Monday, 28'th Aug 2023
With the phase III LEAP-010 study failing to show an overall survival benefit for patients with recurrent or metastatic HNSCC, Merck (MRK) and Eisai have decided to close the study.
Oncology Market's Huge Potential Puts These Stocks in Focus
09:46am, Monday, 28'th Aug 2023
The oncology treatment market has been experiencing significant growth lately. Companies like Regeneron Pharmaceuticals (REGN), Merck & Co. (MRK), Novartis (NVS) and AstraZeneca (AZN) have made meanin
